Sage Therapeutics, Inc. (SAGE) Reports Q3 Loss, Lags Revenue Estimates

Sage Therapeutics, Inc. (SAGE) delivered earnings and revenue surprises of -20.11% and -28.04%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for…